▁The 3.166015625
▁introduction 8.3828125
▁of 0.2237548828125
▁the 1.259765625
▁study 9.15625
▁describes 4.40234375
▁the 0.354736328125
▁apparent 10.015625
▁link 5.33984375
▁between 0.1817626953125
▁pain 7.2890625
▁and 0.344482421875
▁dem 8.3046875
oral 1.8251953125
ization 0.2149658203125
. 1.4951171875
▁Chron 7.765625
ic 0.01140594482421875
▁pain 0.1749267578125
▁is 1.2392578125
▁still 7.2578125
▁considered 2.8046875
▁to 1.7138671875
▁be 0.0560302734375
▁an 2.57421875
▁extreme 6.51171875
▁issue 5.68359375
▁among 3.61328125
▁at 9.5625
▁least 0.626953125
▁ 0.56982421875
8 3.478515625
% 1.693359375
▁of 0.08966064453125
▁the 0.39111328125
▁residents 7.46875
▁of 0.88916015625
▁progress 11.8984375
ive 0.403076171875
▁countries 0.7998046875
. 0.67626953125
▁Chron 3.908203125
ic 0.0025424957275390625
▁pain 0.09381103515625
▁is 1.05859375
▁always 5.875
▁accompanied 2.765625
▁by 0.1234130859375
▁negative 3.95703125
▁emot 0.91015625
ional 1.4423828125
▁experiences 3.001953125
▁and 2.080078125
▁blocks 11.375
▁a 3.318359375
▁person 0.61669921875
’ 0.8115234375
s 0.0009813308715820312
▁ability 1.5751953125
▁to 0.0361328125
▁receive 7.14453125
▁joy 3.927734375
▁and 1.265625
▁satisfaction 3.1171875
▁from 0.8125
▁life 0.60302734375
. 0.2091064453125
▁They 7.08203125
▁manage 8.1796875
▁pain 3.328125
▁successfully 7.48046875
, 1.833984375
▁but 1.0625
▁the 2.544921875
▁past 8.265625
▁few 4.54296875
▁dec 1.3388671875
ades 6.473064422607422e-05
▁indicated 8.1171875
▁the 2.255859375
▁growing 3.650390625
▁concern 3.37109375
▁regarding 2.779296875
▁op 5.6015625
iate 3.169921875
▁ab 1.888671875
use 0.0194244384765625
▁in 2.744140625
▁forms 10.359375
▁of 0.177978515625
▁over 3.556640625
d 0.3515625
ose 0.25048828125
▁and 0.8505859375
▁add 1.115234375
iction 0.0243377685546875
. 0.252685546875
▁The 1.6630859375
▁research 2.923828125
▁investig 5.296875
ates 0.430419921875
▁the 0.444580078125
▁development 5.96484375
▁of 0.15869140625
▁de 5.453125
pression 0.269775390625
▁and 1.154296875
▁anx 1.880859375
iety 0.0017232894897460938
▁among 1.673828125
▁patients 1.7646484375
▁receiving 3.939453125
▁ph 6.0078125
arma 2.259765625
ce 0.00566864013671875
ut 0.00010025501251220703
ical 0.012725830078125
▁op 2.005859375
io 1.04296875
ids 0.301513671875
▁and 2.6328125
▁medical 5.20703125
▁mar 1.130859375
iju 0.0020313262939453125
ana 5.6624412536621094e-05
▁( 2.939453125
MM 1.142578125
) 2.880859375
▁as 2.4140625
▁severe 10.3984375
▁pain 0.74609375
kill 3.2734375
ers 0.00047707557678222656
. 0.223876953125
▁A 4.33984375
▁more 6.390625
▁manage 8.6875
able 0.0008749961853027344
▁and 2.234375
▁sa 2.876953125
fer 6.890296936035156e-05
▁alternative 1.8984375
▁might 5.734375
▁be 0.28271484375
▁medical 3.158203125
▁mar 0.197509765625
iju 0.0007386207580566406
ana 0.00015556812286376953
. 1.279296875
▁The 1.4921875
▁study 1.681640625
▁was 2.9609375
▁conducted 0.935546875
▁in 1.533203125
▁the 1.5537109375
▁form 2.431640625
▁of 0.0037841796875
▁collection 11.125
▁and 1.1240234375
▁analysis 0.44384765625
▁of 0.0207061767578125
▁statistical 4.53125
▁data 0.1761474609375
. 1.609375
▁It 2.744140625
▁comp 5.796875
ares 0.06402587890625
▁the 0.61669921875
▁effic 5.828125
acy 0.002574920654296875
▁of 0.275390625
▁pres 5.22265625
cri 2.22265625
ptions 1.74609375
▁and 2.26171875
▁exam 5.21484375
ines 0.058685302734375
▁the 0.41845703125
▁possibility 4.05859375
▁of 0.1259765625
▁post 8.484375
- 0.52978515625
tre 2.279296875
at 0.0024166107177734375
ment 0.005184173583984375
▁de 0.970703125
pression 0.028289794921875
. 1.8017578125
▁However 6.23828125
, 0.005191802978515625
▁the 0.83447265625
▁legal 7.2421875
▁status 1.255859375
▁and 3.0078125
▁novel 10.3828125
ty 0.2734375
▁of 0.10443115234375
▁this 2.974609375
▁drug 2.337890625
▁do 4.61328125
▁not 0.0157012939453125
▁allow 0.5458984375
▁finding 6.390625
▁a 1.9658203125
▁large 2.583984375
▁number 0.814453125
▁of 0.003208160400390625
▁studies 2.244140625
▁on 1.541015625
▁its 1.8349609375
▁effect 1.9013671875
iveness 0.33544921875
. 0.599609375
▁Part 7.00390625
icip 0.465087890625
ants 0.0626220703125
▁were 1.1708984375
▁rec 3.3984375
ru 0.0015573501586914062
ited 0.00012755393981933594
▁for 3.83984375
▁six 6.2890625
▁months 0.55029296875
▁at 4.19140625
▁two 2.859375
▁major 4.3671875
▁pain 2.58984375
▁relief 4.29296875
▁cent 0.775390625
ers 0.10821533203125
▁in 0.74755859375
▁Israel 4.69140625
. 0.387939453125
▁This 4.2265625
▁research 2.22265625
▁paper 4.76953125
▁a 3.111328125
ims 0.0026607513427734375
▁to 0.12066650390625
▁analyze 3.103515625
▁levels 9.21875
▁of 0.030731201171875
▁de 0.78515625
pression 0.03948974609375
▁and 0.3505859375
▁anx 0.0806884765625
iety 0.00041866302490234375
▁among 0.9150390625
▁people 3.40625
▁receiving 2.283203125
▁ther 6.984375
apy 0.087890625
▁by 4.4609375
▁comparing 6.67578125
▁the 1.7421875
▁effects 2.943359375
▁of 0.056396484375
▁ph 2.73046875
arma 0.037322998046875
ce 0.0023193359375
ut 5.030632019042969e-05
ical 0.0037670135498046875
▁op 0.2335205078125
io 0.13916015625
ids 0.046661376953125
▁and 0.350341796875
▁MM 0.60400390625
. 0.333984375
▁The 1.2890625
▁research 2.076171875
ers 2.0078125
▁used 2.44921875
▁The 6.80859375
▁De 2.98828125
pression 0.0263214111328125
▁Module 6.75
▁of 0.91015625
▁the 0.2349853515625
▁Pat 3.41015625
ient 0.00978851318359375
▁Health 0.029266357421875
▁Question 0.0184478759765625
naire 0.0269775390625
▁and 2.5546875
▁the 0.81201171875
▁General 1.1728515625
ized 0.61865234375
▁An 0.005336761474609375
x 7.593631744384766e-05
iety 0.0005211830139160156
▁Dis 0.25
order 0.022613525390625
▁Sc 1.5048828125
ale 0.003070831298828125
▁to 1.12890625
▁interview 7.9453125
▁participants 2.0
, 4.22265625
▁evaluate 4.80859375
▁their 0.85986328125
▁answers 3.6640625
, 0.36669921875
▁and 0.04901123046875
▁conduct 4.56640625
▁the 1.9560546875
▁study 2.322265625
. 0.08880615234375
▁To 5.3125
▁specifically 10.78125
▁evaluate 3.0390625
▁and 4.5625
▁compare 0.8115234375
▁the 0.4765625
▁prob 9.8125
abilities 0.05438232421875
▁of 0.10504150390625
▁de 0.8701171875
pression 0.03460693359375
▁or 4.2734375
▁anx 0.054718017578125
iety 0.000637054443359375
▁among 1.5703125
▁the 1.8798828125
▁diverse 9.53125
▁groups 0.923828125
, 0.6748046875
▁the 0.60595703125
▁study 2.625
▁used 1.486328125
▁multiple 5.35546875
▁log 0.5625
istic 0.0250396728515625
▁regression 0.276123046875
▁analysis 1.359375
▁and 2.623046875
▁chose 8.421875
▁medical 5.4453125
▁mar 0.08209228515625
iju 0.001171112060546875
ana 4.935264587402344e-05
▁as 0.483154296875
▁the 0.78466796875
▁control 3.06640625
▁group 0.55615234375
. 0.278564453125
▁There 5.25390625
▁is 1.68359375
▁currently 5.59375
▁a 1.1748046875
▁severe 5.265625
▁lack 1.623046875
▁of 0.01387786865234375
▁information 2.705078125
▁about 1.50390625
▁the 0.6357421875
▁effects 2.291015625
▁of 0.0838623046875
▁op 3.865234375
i 2.544921875
ates 0.0071563720703125
. 3.01953125
▁Thus 4.51171875
, 0.035125732421875
▁research 3.619140625
ers 0.375732421875
▁can 3.396484375
▁compare 4.49609375
▁the 0.7119140625
▁effects 2.14453125
▁of 0.11859130859375
▁medic 4.49609375
ations 1.4228515625
▁on 1.8740234375
▁patients 1.8544921875
▁of 4.66796875
▁diverse 4.0
▁age 2.0390625
▁groups 1.375
, 1.2080078125
▁background 4.3359375
s 0.11700439453125
, 0.0268402099609375
▁physical 5.90625
▁conditions 1.2177734375
, 0.04974365234375
▁emot 7.1015625
ional 0.0452880859375
▁states 1.3125
, 0.048309326171875
▁and 0.3193359375
▁so 3.220703125
▁on 0.5361328125
. 0.133056640625
▁This 2.353515625
▁type 5.19140625
▁of 0.00238037109375
▁study 1.4384765625
▁is 1.5888671875
▁the 3.5234375
▁most 1.67578125
▁reve 7.1171875
aling 0.0006537437438964844
▁and 1.3369140625
▁inclus 6.33203125
ive 0.0006871223449707031
, 2.447265625
▁as 1.6259765625
▁it 0.412353515625
▁contains 4.91796875
▁direct 7.2421875
▁responses 5.26171875
▁from 0.54736328125
▁a 3.576171875
▁large 0.99951171875
▁number 0.493408203125
▁of 0.002620697021484375
▁participants 1.2275390625
. 0.59619140625
▁Specifically 8.5859375
, 0.053131103515625
▁it 2.455078125
▁concerns 7.23046875
▁the 0.974609375
▁emot 5.5546875
ional 0.029022216796875
▁condition 4.09375
▁of 0.26123046875
▁patients 1.025390625
▁experien 5.75390625
cing 3.361701965332031e-05
▁chron 1.17578125
ic 0.00029158592224121094
▁pain 0.09051513671875
. 0.92919921875
▁Because 6.5078125
▁the 1.994140625
▁survey 5.984375
▁responses 5.9921875
▁were 1.4287109375
▁thoroughly 8.125
▁anonymous 3.54296875
, 0.2109375
▁the 1.1748046875
▁research 1.431640625
ers 0.335205078125
▁were 1.8212890625
▁unable 3.830078125
▁to 0.0015392303466796875
▁carefully 8.7265625
▁analyze 2.03125
▁each 3.11328125
▁patient 1.7841796875
’ 0.423828125
s 0.0007328987121582031
▁reaction 5.32421875
▁and 2.05078125
▁compare 3.890625
▁it 1.0595703125
▁to 0.4423828125
▁the 1.001953125
▁actual 6.17578125
▁states 8.671875
▁of 0.254638671875
▁condition 8.0546875
. 0.72119140625
▁It 3.302734375
▁helps 7.05078125
▁to 0.634765625
▁system 7.67578125
at 0.56298828125
ize 0.0018129348754882812
▁and 1.705078125
▁class 4.4921875
ify 0.0021648406982421875
▁distinct 7.51953125
▁kinds 6.26953125
▁of 0.016571044921875
▁information 4.765625
▁for 4.08984375
▁subsequent 5.24609375
▁un 9.25
comp 4.92578125
licated 0.033721923828125
▁services 11.8046875
. 0.71533203125
▁All 5.53125
▁tools 8.8046875
▁in 4.71484375
▁the 0.8232421875
▁form 4.828125
▁of 0.01727294921875
▁question 1.0126953125
na 0.01221466064453125
ires 4.398822784423828e-05
▁and 1.3408203125
▁scales 2.537109375
▁have 3.0703125
▁already 4.51171875
▁been 0.256103515625
▁used 2.375
▁and 1.931640625
▁proved 2.892578125
▁their 1.3310546875
▁effic 2.763671875
acy 0.0024585723876953125
▁for 3.6171875
▁collect 3.775390625
ing 0.00580596923828125
▁analyt 7.26171875
ical 0.09405517578125
▁data 0.263916015625
. 0.41259765625
▁Perhaps 8.890625
▁some 4.8125
▁patients 2.8515625
▁tend 5.8515625
▁to 0.0238800048828125
▁ex 2.328125
agger 0.0025959014892578125
ate 0.0012941360473632812
▁their 0.90625
▁de 3.705078125
press 1.5
ive 0.041107177734375
▁state 2.5859375
▁or 1.654296875
▁vice 6.43359375
▁vers 0.019927978515625
a 0.00022423267364501953
, 0.90234375
▁de 7.0859375
- 2.21875
emph 0.400390625
as 0.0025482177734375
ize 0.05279541015625
▁serious 6.2578125
▁difficulties 5.69140625
. 0.79541015625
▁The 2.09765625
▁analysis 4.3671875
▁of 0.6806640625
▁any 7.05859375
▁human 6.80078125
▁reaction 3.11328125
▁has 4.703125
▁a 1.677734375
▁high 2.875
▁potential 3.28515625
▁of 2.138671875
▁subject 1.8486328125
iveness 3.880859375
▁and 1.4482421875
▁bias 2.291015625
, 1.8505859375
▁especially 2.75
▁regarding 3.908203125
▁people 4.66796875
▁in 3.03515625
▁severe 2.45703125
▁pain 0.75341796875
▁and 2.310546875
▁un 5.5625
stable 1.236328125
▁emot 0.63671875
ional 0.062225341796875
▁condition 2.330078125
. 0.053070068359375
▁Part 5.3671875
icip 0.254638671875
ants 0.07501220703125
▁were 1.6435546875
▁rec 1.8857421875
ru 0.0004451274871826172
ited 9.036064147949219e-05
▁for 1.0966796875
▁six 0.150146484375
▁months 0.0034885406494140625
▁at 0.1607666015625
▁two 0.039031982421875
▁major 0.03778076171875
▁pain 0.020294189453125
▁relief 0.02252197265625
▁cent 0.00994873046875
ers 0.0010519027709960938
▁in 0.0309600830078125
▁Israel 0.009613037109375
. 0.142333984375
▁However 4.64453125
, 0.0021610260009765625
▁this 2.609375
▁method 3.607421875
▁of 1.5380859375
▁research 2.4609375
▁is 1.416015625
▁way 9.5546875
▁more 1.1806640625
▁resource 6.29296875
- 1.2861328125
int 1.0751953125
ensive 0.01165008544921875
▁and 0.89794921875
▁energy 9.046875
- 0.0762939453125
consum 0.347412109375
ing 0.0015802383422851562
. 1.2119140625
▁All 4.92578125
▁patients 2.748046875
▁experienced 5.18359375
▁chron 0.90625
ic 0.00024318695068359375
▁pain 0.1392822265625
▁for 2.798828125
▁at 0.7890625
▁least 0.0015707015991210938
▁ 1.7412109375
3 1.5625
▁months 0.323486328125
. 1.171875
▁More 5.9375
▁accurate 5.12109375
▁answers 4.23828125
▁could 2.8828125
▁be 0.275390625
▁obtained 0.89306640625
▁by 1.3896484375
▁professional 5.84375
▁psych 1.30859375
olog 0.2607421875
ists 0.0005965232849121094
▁via 7.234375
▁personal 2.755859375
▁communication 3.904296875
▁and 1.833984375
▁behavior 6.33203125
al 0.216796875
▁analysis 2.001953125
. 0.228271484375
▁The 1.5498046875
▁remaining 8.9921875
▁ten 6.94140625
▁participants 1.7294921875
▁who 3.8125
▁did 1.7734375
▁not 0.007640838623046875
▁receive 2.548828125
▁ph 4.17578125
arma 0.03228759765625
ce 0.0010805130004882812
ut 9.655952453613281e-06
ical 0.0010595321655273438
▁op 0.314208984375
io 0.1282958984375
ids 0.0298919677734375
▁and 2.359375
▁medical 1.1513671875
▁mar 0.03289794921875
iju 0.0003223419189453125
ana 1.8715858459472656e-05
▁were 0.8828125
▁with 7.94921875
dra 0.11529541015625
wn 1.0728836059570312e-06
▁from 0.3486328125
▁the 0.169189453125
▁analysis 2.57421875
▁in 4.85546875
▁the 1.373046875
▁research 4.45703125
. 0.875
▁The 1.4013671875
▁study 1.9638671875
▁conducted 4.51171875
▁a 2.2421875
▁correlation 6.4375
▁type 9.078125
▁of 0.2978515625
▁research 0.9189453125
▁with 3.509765625
▁variable 8.703125
▁measures 5.08203125
. 0.908203125
▁It 2.29296875
▁evaluated 5.546875
▁the 0.529296875
▁inter 6.19921875
dep 2.46875
end 0.00018727779388427734
ence 0.007293701171875
▁of 0.638671875
▁various 3.41015625
▁factors 0.96044921875
▁that 3.005859375
▁affected 3.974609375
▁the 0.420166015625
▁physical 6.32421875
▁and 0.339599609375
▁emot 0.51220703125
ional 0.0001081228256225586
▁condition 1.3134765625
▁of 0.06573486328125
▁patients 0.861328125
▁experien 3.36328125
cing 9.655952453613281e-06
▁chron 0.296630859375
ic 0.00019812583923339844
▁pain 0.0173187255859375
. 0.103759765625
▁In 3.638671875
▁turn 5.29296875
, 0.0014085769653320312
▁people 6.41015625
▁on 5.3828125
▁op 2.181640625
i 0.8203125
ates 0.00153350830078125
▁were 2.06640625
▁more 1.3330078125
▁likely 0.392578125
▁to 0.023162841796875
▁report 3.193359375
▁major 6.2734375
▁de 0.268798828125
press 0.74267578125
ive 0.00318145751953125
▁dis 1.19921875
orders 1.3369140625
. 1.591796875
▁The 1.6064453125
▁question 5.1796875
na 0.869140625
ires 0.00011289119720458984
▁used 2.404296875
▁different 7.23046875
▁variable 7.85546875
▁measures 0.394775390625
▁to 2.04296875
▁collect 2.47265625
▁information 1.7705078125
. 1.5625
▁The 1.4140625
▁study 2.21875
▁included 4.05078125
▁ 1.4638671875
8 3.041015625
9 2.57421875
0 3.12109375
▁participants 1.1494140625
, 1.685546875
▁of 2.734375
▁which 0.47265625
▁ 0.1396484375
4 1.5625
7 2.576171875
4 2.671875
▁( 3.302734375
5 0.10076904296875
9 5.08984375
%) 0.796875
▁were 0.708984375
▁treated 3.830078125
▁sole 6.65625
ly 0.0005817413330078125
▁with 0.2027587890625
▁op 1.251953125
io 0.57421875
ids 0.1148681640625
, 0.5625
▁ 0.521484375
3 1.2890625
2 2.251953125
9 2.517578125
▁( 0.049407958984375
4 2.541015625
1 1.6953125
%) 0.0750732421875
▁were 1.314453125
▁treated 0.279052734375
▁with 0.393310546875
▁MM 1.125
, 0.363037109375
▁and 0.10211181640625
▁ 0.30712890625
7 2.125
7 2.37890625
▁( 0.115478515625
8 1.9521484375
. 0.95361328125
6 2.478515625
%) 0.058380126953125
▁acquired 11.265625
▁both 1.0185546875
▁( 4.5859375
Fe 8.890625
ing 1.3095703125
old 0.368896484375
▁et 0.9013671875
▁al 0.017669677734375
., 0.166748046875
▁ 0.012298583984375
2 0.0082855224609375
0 0.0002880096435546875
1 0.3076171875
7 1.708984375
). 0.036773681640625
▁Therefore 4.44921875
, 0.00795745849609375
▁it 2.37890625
▁is 0.783203125
▁not 2.63671875
▁possible 1.369140625
▁to 0.0132904052734375
▁compreh 6.3671875
ens 0.10162353515625
ively 0.0065765380859375
▁compare 2.234375
▁patients 4.1796875
▁taking 4.11328125
▁medic 3.80859375
ations 0.54296875
▁with 1.4462890625
▁those 1.451171875
▁who 0.935546875
▁do 1.4755859375
▁not 0.004863739013671875
. 0.71435546875
▁The 1.3935546875
▁pl 11.1640625
ur 0.95654296875
ality 0.00672149658203125
▁of 0.1158447265625
▁anx 8.03125
iety 0.02215576171875
▁contained 10.65625
▁ 1.939453125
4 1.98046875
8 2.57421875
. 1.28515625
4 2.287109375
% 0.338134765625
▁among 2.4921875
▁OP 9.0625
▁patients 1.3203125
, 0.814453125
▁ 0.83837890625
2 1.9423828125
1 2.68359375
. 0.09869384765625
5 2.095703125
% 0.0256805419921875
▁among 0.261474609375
▁MM 0.1552734375
▁patients 0.2354736328125
, 0.038238525390625
▁and 0.052581787109375
▁ 0.10723876953125
3 1.51953125
8 2.54296875
. 0.15966796875
7 2.259765625
% 0.0198974609375
▁among 0.1446533203125
▁OP 2.876953125
MM 4.265625
▁participants 4.22265625
. 0.232421875
▁For 4.98046875
▁example 1.4375
, 0.0025081634521484375
▁the 1.513671875
▁survey 5.1953125
▁showed 3.94140625
▁that 0.409912109375
▁the 2.2734375
▁ratio 6.28125
▁of 0.07818603515625
▁female 4.65625
▁patients 1.001953125
▁was 1.330078125
▁remark 8.671875
ably 0.00023889541625976562
▁higher 0.2318115234375
▁in 2.736328125
▁the 0.673828125
▁op 3.5625
i 1.9833984375
ates 0.01194000244140625
▁group 0.16064453125
▁compared 2.890625
▁to 0.04559326171875
▁the 0.67529296875
▁MM 0.375732421875
▁group 0.26611328125
. 0.281005859375
▁For 4.48828125
▁example 0.884765625
, 0.0018777847290039062
▁it 3.478515625
▁included 4.99609375
▁compreh 8.9296875
ensive 0.055267333984375
▁so 5.828125
cio 0.0014190673828125
- 0.28271484375
dem 0.38134765625
ographic 0.0731201171875
▁data 1.0546875
: 4.890625
▁gender 1.8994140625
, 0.0462646484375
▁age 0.248779296875
, 0.039093017578125
▁country 4.48046875
, 2.486328125
▁type 4.2421875
▁of 0.06695556640625
▁residence 4.27734375
▁( 2.69140625
urban 0.6943359375
/ 1.3935546875
r 0.1788330078125
ural 0.0009317398071289062
), 0.1708984375
▁years 6.5546875
▁of 0.1490478515625
▁education 0.791015625
, 0.0826416015625
▁and 1.6689453125
▁employ 2.697265625
ment 0.0018024444580078125
▁status 0.71728515625
. 0.2008056640625
▁Pat 4.62890625
ients 0.06231689453125
▁were 2.263671875
▁also 2.494140625
▁asked 0.994140625
▁about 0.94580078125
▁their 0.70361328125
▁medical 2.849609375
▁history 0.53173828125
▁over 8.1484375
▁the 0.054962158203125
▁years 4.5859375
▁and 1.6552734375
▁the 1.5244140625
▁current 3.27734375
▁presence 4.8984375
▁of 0.0848388671875
▁any 1.85546875
▁severe 3.6328125
▁dise 1.8515625
ases 8.320808410644531e-05
▁such 4.58203125
▁as 0.0012292861938476562
▁heart 2.484375
▁failure 1.9072265625
, 0.328125
▁di 1.607421875
ab 0.0007529258728027344
etes 0.002437591552734375
, 0.075927734375
▁ar 4.2421875
th 0.185302734375
rit 0.03009033203125
is 0.004367828369140625
, 0.0294189453125
▁and 1.2119140625
▁so 0.767578125
▁on 0.04345703125
. 0.044036865234375
▁In 3.09765625
▁addition 1.5283203125
, 0.125732421875
▁the 1.0361328125
▁record 10.1640625
▁included 1.7958984375
▁a 2.908203125
▁pain 5.20703125
▁measurement 5.17578125
▁scale 0.66259765625
▁from 4.00390625
▁ 0.363037109375
0 0.3466796875
▁to 0.209228515625
▁ 0.005748748779296875
1 0.07025146484375
0 0.0296478271484375
▁to 3.24609375
▁evaluate 1.5927734375
▁dis 6.26171875
com 0.10687255859375
fort 0.00109100341796875
▁feelings 8.625
▁during 4.34375
▁the 0.36962890625
▁last 1.2646484375
▁month 1.8779296875
. 0.2122802734375
▁The 1.3330078125
▁third 7.45703125
▁measure 4.36328125
▁of 2.302734375
▁the 0.72119140625
▁question 2.47265625
naire 0.123291015625
▁was 1.16796875
▁indicated 11.265625
▁by 1.4462890625
▁information 8.3515625
▁on 1.87109375
▁any 4.46484375
▁twelve 14.1953125
- 0.257080078125
month 0.1422119140625
▁and 5.26171875
▁lifetime 0.64892578125
▁drug 3.904296875
▁and 1.8349609375
▁alco 0.11419677734375
hol 5.8650970458984375e-05
▁consumption 4.47265625
. 0.43603515625
▁The 1.26171875
▁pl 5.578125
ur 0.0036182403564453125
ality 1.3113021850585938e-05
▁of 0.0230712890625
▁de 1.6259765625
press 1.6982421875
ive 0.009857177734375
▁dis 1.0283203125
orders 0.12548828125
▁among 2.513671875
▁patients 1.3720703125
▁in 2.923828125
▁the 0.371826171875
▁op 0.7783203125
i 0.41259765625
ates 0.0017490386962890625
, 7.9140625
▁medical 2.701171875
▁mar 0.01544189453125
iju 0.0006852149963378906
ana 5.125999450683594e-05
, 0.1226806640625
▁and 0.0595703125
▁mixed 2.736328125
▁OP 5.8984375
MM 0.297607421875
▁groups 0.3994140625
▁number 8.359375
ed 0.0110931396484375
▁ 0.11260986328125
5 2.46875
7 2.58203125
. 0.25439453125
1 2.2109375
%, 0.0997314453125
▁ 0.00335693359375
2 1.3486328125
2 2.310546875
. 0.076171875
3 2.298828125
%, 0.04345703125
▁and 0.051544189453125
▁ 0.0011816024780273438
5 2.921875
1 1.9716796875
. 0.109619140625
4 2.134765625
%, 0.1507568359375
▁respectively 0.0171966552734375
. 0.1893310546875
▁One 5.4921875
▁of 0.59912109375
▁the 0.0290069580078125
▁major 2.87109375
▁limitations 2.21875
▁is 2.1875
▁the 0.52783203125
▁ins 4.6640625
u 0.052276611328125
fficient 0.0584716796875
ly 3.740234375
▁high 2.896484375
▁response 3.013671875
▁rate 0.092529296875
, 2.298828125
▁ 4.28125
5 1.8134765625
7 2.373046875
% 2.041015625
▁instead 5.76953125
▁of 0.0020427703857421875
▁ 0.56005859375
7 1.7578125
0 0.473388671875
% 1.5751953125
▁( 1.8720703125
Fe 1.056640625
ing 0.0015316009521484375
old 0.00033974647521972656
▁et 0.02459716796875
▁al 0.0012769699096679688
., 0.01015472412109375
▁ 0.0016546249389648438
2 0.0001550912857055664
0 8.177757263183594e-05
1 0.0010166168212890625
7 0.007801055908203125
). 0.00914764404296875
▁Among 5.4375
▁all 2.7421875
▁participants 1.4462890625
▁in 3.068359375
▁the 0.1922607421875
▁study 0.8173828125
, 0.05999755859375
▁ 0.79833984375
4 1.876953125
2 2.478515625
. 0.8232421875
2 2.2265625
% 0.047271728515625
▁suffered 3.81640625
▁from 0.046173095703125
▁de 1.7216796875
pression 0.53564453125
, 1.123046875
▁and 1.509765625
▁ 0.207763671875
3 1.3359375
7 2.330078125
% 2.712890625
▁experienced 2.271484375
▁excess 7.34765625
ive 0.0289459228515625
▁anx 0.2198486328125
iety 0.00209808349609375
. 0.28173828125
▁Pat 4.0234375
ients 0.0259552001953125
▁who 2.0234375
▁took 2.41796875
▁only 2.955078125
▁MM 1.5087890625
▁or 3.140625
▁mixed 2.923828125
▁medic 2.0390625
ations 0.259033203125
▁course 13.53125
▁had 1.771484375
▁a 1.2783203125
▁significantly 2.125
▁more 5.91796875
▁stable 3.0078125
▁emot 0.849609375
ional 0.0005793571472167969
▁state 0.6484375
▁and 2.056640625
▁cop 7.5703125
ed 0.1142578125
▁with 0.36669921875
▁pain 1.2890625
▁more 1.591796875
▁manage 7.24609375
able 1.4423828125
. 0.580078125
▁Pat 3.716796875
ients 0.0128173828125
▁who 1.2314453125
▁took 1.263671875
▁strong 10.0078125
▁op 0.740234375
i 0.61572265625
ates 0.0024089813232421875
▁were 1.7255859375
▁t 9.78125
ended 1.1025390625
▁to 0.00787353515625
▁place 10.1953125
▁their 2.15234375
▁pain 2.87890625
▁on 1.615234375
▁a 0.455810546875
▁scale 1.755859375
▁of 0.3203125
▁ 0.09930419921875
9 2.34375
▁to 2.341796875
▁ 0.01171112060546875
1 0.0034580230712890625
0 0.004047393798828125
▁( 2.9296875
Fe 0.76123046875
ing 0.0018548965454101562
old 0.00027871131896972656
▁et 0.010345458984375
▁al 0.0019197463989257812
., 0.006954193115234375
▁ 0.0017852783203125
2 0.00014925003051757812
0 0.00011110305786132812
1 0.00066375732421875
7 0.0038585662841796875
). 0.00833892822265625
▁It 3.09375
▁can 3.533203125
▁be 0.2685546875
▁fairly 7.6171875
▁explained 3.37109375
▁by 0.2022705078125
▁the 0.322021484375
▁weak 6.984375
▁focus 8.65625
▁of 0.9931640625
▁respond 7.42578125
ents 0.06719970703125
▁who 2.9921875
▁have 4.12109375
▁overcome 7.73828125
▁severe 2.27734375
▁pain 1.0
▁sens 6.62890625
ations 0.1826171875
▁and 1.328125
▁de 4.9921875
press 0.9931640625
ive 0.0628662109375
▁episodes 2.564453125
. 0.5625
▁It 2.88671875
▁is 1.001953125
▁not 2.669921875
▁clear 3.306640625
▁how 1.970703125
▁to 3.041015625
▁use 3.8671875
▁these 2.1875
▁statistics 3.916015625
, 3.064453125
▁as 0.88916015625
▁they 1.673828125
▁still 5.53515625
▁may 5.37890625
▁be 1.1748046875
▁relevant 6.41015625
▁for 1.70703125
▁the 1.9453125
▁overall 5.09375
▁analysis 2.6171875
. 0.9716796875
▁They 4.64453125
▁were 3.048828125
▁also 2.638671875
▁an 8.03125
gu 7.91796875
ished 0.0665283203125
▁em 7.1796875
otion 0.0040130615234375
ally 0.002063751220703125
▁and 0.970703125
▁react 7.14453125
ed 0.0270233154296875
▁rad 8.625
ically 0.0002968311309814453
▁neg 5.28125
atively 0.0012216567993164062
▁to 0.228515625
▁almost 5.9921875
▁all 1.376953125
▁survey 3.966796875
▁questions 0.2315673828125
. 0.316162109375
